Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14037)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 20, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mazzanti R, Arena U, Tassi R. Hepatocellular carcinoma: Where are we? World J Exp Med 2016; 6(1): 21-36 [PMID: 26929917 DOI: 10.5493/wjem.v6.i1.21] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i1/21.htm |
| Number | Citing Articles |
| 1 |
Rinku Dutta, Ram I. Mahato. Recent advances in hepatocellular carcinoma therapy. Pharmacology & Therapeutics 2017; 173: 106 doi: 10.1016/j.pharmthera.2017.02.010
|
| 2 |
Adriana Unić, Lovorka Derek, Marko Duvnjak, Leonardo Patrlj, Mislav Rakić, Milan Kujundžić, Vesna Renjić, Nikola Štoković, Petra Dinjar, Anita Jukic, Ivica Grgurević. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(3): 355 doi: 10.1177/0004563217726808
|
| 3 |
Yaoye Tao, Jianguo Wang, Xiao Xu. Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00184
|
| 4 |
Mei-Xi Wang, Dong Chen, Yuan-Yuan Zhao, Bo Yang, Ji-Pin Jiang, Fan-Jun Zeng, Lai Wei, Zhi-Shui Chen. Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation. Hepatobiliary & Pancreatic Diseases International 2020; 19(4): 378 doi: 10.1016/j.hbpd.2020.06.008
|
| 5 |
Junli Ma, Shan Zeng, Yan Zhang, Ganlu Deng, Yanling Qu, Cao Guo, Ling Yin, Ying Han, Changjing Cai, Yiyi Li, Guqi Wang, Herbert L. Bonkovsky, Hong Shen. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Letters 2017; 411: 117 doi: 10.1016/j.canlet.2017.09.041
|
| 6 |
Niko Hiltunen, Niko Kemi, Juha P. Väyrynen, Jan Böhm, Joonas H. Kauppila, Heikki Huhta, Olli Helminen, Luwen Zhang. Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis. PLOS ONE 2024; 19(5): e0302813 doi: 10.1371/journal.pone.0302813
|
| 7 |
Laura Chulenbayeva, Oralbek Ilderbayev, Dametken Suleymeneva, Aizhan Kaliyeva, Symbat Kabdykanov, Madiyar Nurgaziyev, Ayaulym Nurgozhina, Shynggys Sergazy, Samat Kozhakhmetov, Almagul Kushugulova, Ahmad Mansour. Prolonged Inhalation Exposure to Coal Dust on Irradiated Rats and Consequences. The Scientific World Journal 2022; 2022: 1 doi: 10.1155/2022/8824275
|
| 8 |
K. Okrah, S. Tarighat, B. Liu, H. Koeppen, M. C. Wagle, G. Cheng, C. Sun, A. Dey, M. T. Chang, T. Sumiyoshi, Z. Mounir, C. Cummings, G. Hampton, L. Amler, J. Fridlyand, P. S. Hegde, S. J. Turley, M. R. Lackner, S. M. Huang. Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0068-8
|
| 9 |
Bhagyalakshmi Nair, Ruby John Anto, Sabitha M, Lekshmi R. Nath. Kaempferol-Mediated Sensitization Enhances Chemotherapeutic Efficacy of Sorafenib Against Hepatocellular Carcinoma: An In Silico and In Vitro Approach. Advanced Pharmaceutical Bulletin 2020; 10(3): 472 doi: 10.34172/apb.2020.058
|
| 10 |
Tatiana Kisseleva, David Brenner. Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews Gastroenterology & Hepatology 2021; 18(3): 151 doi: 10.1038/s41575-020-00372-7
|
| 11 |
Elena De Mattia, Erika Cecchin, Jerry Polesel, Alessia Bignucolo, Rossana Roncato, Francesco Lupo, Marina Crovatto, Angela Buonadonna, Claudio Tiribelli, Giuseppe Toffoli. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World Journal of Gastroenterology 2017; 23(36): 6674-6684 doi: 10.3748/wjg.v23.i36.6674
|
| 12 |
Shakir Saleem, Imran Kazmi, Aftab Ahmad, Mohammed F. Abuzinadah, Ali Samkari, Huda M. Alkrathy, Ruqaiyah Khan. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats. Nutrition and Cancer 2020; 72(1): 170 doi: 10.1080/01635581.2019.1614199
|
| 13 |
Vahid Mansouri, Nima Rezaei. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 1 doi: 10.1007/16833_2022_70
|
| 14 |
Agnieszka Adamek, Aldona Kasprzak. Insulin-Like Growth Factor (IGF) System in Liver Diseases. International Journal of Molecular Sciences 2018; 19(5): 1308 doi: 10.3390/ijms19051308
|
| 15 |
David Roife, Juan A. Santamaria‐Barria, Lillian S. Kao, Tien C. Ko, Curtis J. Wray. Surrogate indicators of quality are associated with survival following surgical treatment for hepatocellular carcinoma. Journal of Surgical Oncology 2018; 118(3): 463 doi: 10.1002/jso.25190
|
| 16 |
Yuping Bai, Wenbo Qi, Le Liu, Jing Zhang, Lan Pang, Tiejun Gan, Pengfei Wang, Chen Wang, Hao Chen. Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.637418
|
| 17 |
Christian P. Strassburg. HCC-Associated Liver Transplantation - Where Are the Limits and What Are the New Regulations?. Visceral Medicine 2016; 32(4): 263 doi: 10.1159/000446385
|
| 18 |
Imge Kunter, Niloufar Zabib, Fatih Göger, Müberra Koşar. New data for endemic Phlomis brevibracteata Turrill from North Cyprus: biological activities and chemical composition. Turkish Journal of Biochemistry 2023; 48(5): 475 doi: 10.1515/tjb-2023-0012
|
| 19 |
Baharan Fekry, Aleix Ribas-Latre, Corrine Baumgartner, Jonathan R. Deans, Christopher Kwok, Pooja Patel, Loning Fu, Rebecca Berdeaux, Kai Sun, Mikhail G. Kolonin, Sidney H. Wang, Seung-Hee Yoo, Frances M. Sladek, Kristin Eckel-Mahan. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma. Nature Communications 2018; 9(1) doi: 10.1038/s41467-018-06648-6
|
| 20 |
Irina Ivanova Ivanova, Sonya Banova, Milko Mirchev, Iskren Kotzev, Alexander Zlatarov, Anton Tonev, Nikola Kolev, Svetomir Chakarov, Chavdar Bachvarov, Boyan Balev, Yana Bocheva, Maria Tzaneva. Management of hepatocellular carcinoma: a study on 240 patients in a single referral center. Scripta Scientifica Medica 2018; 50(2): 19 doi: 10.14748/ssm.v50i2.4441
|
| 21 |
Amr A. Waly, Nada El-Ekiaby, Reem A. Assal, Mohamed M. Abdelrahman, Karim A. Hosny, Hend M. El Tayebi, Gamal Esmat, Kai Breuhahn, Ahmed I. Abdelaziz. Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma. Frontiers in Physiology 2019; 9 doi: 10.3389/fphys.2018.01918
|
| 22 |
S. C. Faria, T. Sagebiel, M. Patnana, V. Cox, C. Viswanathan, C. Lall, A. Qayyum, P. R. Bhosale. Tumor markers: myths and facts unfolded. Abdominal Radiology 2019; 44(4): 1575 doi: 10.1007/s00261-018-1845-0
|
| 23 |
Chang-Jiang Lei, Jia-Ni Liu, Rong Wu, Zhi-Xiong Long, Jiang-Zhou Zhang, Dan Tao, Yan-Ping Liu. Change of the peripheral blood immune pattern and its correlation with prognosis in patients with liver cancer treated by sorafenib. Asian Pacific Journal of Tropical Medicine 2016; 9(6): 592 doi: 10.1016/j.apjtm.2016.04.019
|
| 24 |
Asmaa M. Zahran, Mona H. Abdel-Rahim, Ahmed Refaat, Mona Sayed, Mostafa M. Othman, Lamiaa M. R. Khalak, Helal F. Hetta. Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis. Acta Oncologica 2020; 59(1): 33 doi: 10.1080/0284186X.2019.1657940
|
| 25 |
Ying Zhu, Kun-Bin Ke, Zhong-Kun Xia, Hong-Jian Li, Rong Su, Chao Dong, Feng-Mei Zhou, Lin Wang, Rong Chen, Shi-Guo Wu, Hui Zhao, Peng Gu, Kwong-Sak Leung, Man-Hon Wong, Gang Lu, Jian-Ying Zhang, Bing-Hua Jiang, Jian-Ge Qiu, Xi-Nan Shi, Marie Chia-mi Lin. Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma. Molecular Medicine 2021; 27(1) doi: 10.1186/s10020-021-00269-4
|
| 26 |
S. E. Voskanyan, V. S. Rudakov, M. V. Shabalin, A. I. Artemyev, A. N. Bashkov, I. Yu. Kolyshev, A. S. Zhurbin, E. V. Naidenov, M. V. Popov. “Reversal” ALPPS in patient with hepatocellular carcinoma and liver cirrhosis. First clinical case in Russia. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(3): 142 doi: 10.16931/1995-5464.2021-3-142-148
|
| 27 |
Peng Yi, Bin Wu, Da Deng, Guang Zhang, Jian Li. Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9295
|
| 28 |
Luca Sanna, Irene Marchesi, Mariarosa A. B. Melone, Luigi Bagella. The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma. Journal of Cellular Physiology 2018; 233(9): 6508 doi: 10.1002/jcp.26545
|
| 29 |
Jinzhao Yang, Jie Chen, Qingqing Li, Ren-ai Xu, Xiaohai Chen. Effects of three flavonoids on the metabolism of lenvatinib. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1438259
|
| 30 |
Manabu WATANABE. Current status, issues, and perspectives in genome research of dogs. The Journal of Animal Genetics 2016; 44(2): 69 doi: 10.5924/abgri.44.69
|
| 31 |
Merricka C. Livingstone, Natalie M. Johnson, Bill D. Roebuck, Thomas W. Kensler, John D. Groopman. Serum miR‐182 is a predictive biomarker for dichotomization of risk of hepatocellular carcinoma in rats. Molecular Carcinogenesis 2019; 58(11): 2017 doi: 10.1002/mc.23093
|
| 32 |
Nicola Fusco, Silvano Bosari. <i>HER2</i> aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists. World Journal of Gastroenterology 2016; 22(35): 7926-7937 doi: 10.3748/wjg.v22.i35.7926
|
| 33 |
Esmat Abdi, Saeid Latifi-Navid. Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk. Personalized Medicine 2023; 20(2): 193 doi: 10.2217/pme-2021-0156
|
| 34 |
Hsiao‐Chen Tu, Yung‐Chun Hsiao, Wan‐Yu Yang, Shin‐Lin Tsai, Hua‐Kuo Lin, Chong‐Yi Liao, Jeng‐Wei Lu, Yu‐Ting Chou, Horng‐Dar Wang, Chiou‐Hwa Yuh. Up‐regulation of golgi α‐mannosidase IA and down‐regulation of golgi α‐mannosidase IC activates unfolded protein response during hepatocarcinogenesis. Hepatology Communications 2017; 1(3): 230 doi: 10.1002/hep4.1032
|
| 35 |
Yuki Haga, Tatsuo Kanda, Masato Nakamura, Shingo Nakamoto, Reina Sasaki, Koji Takahashi, Shuang Wu, Osamu Yokosuka, Olorunseun Ogunwobi. Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines. PLOS ONE 2017; 12(3): e0174153 doi: 10.1371/journal.pone.0174153
|
| 36 |
M. Bina Possatto, E.C. de Ataíde, C.A. Fazzio Escanhoela, T. Sevá-Pereira, R. de Cassia Martins Alves da Silva, H. Felicio, L.R. de Navarro Amado, R. Ferreira da Silva, A. Soares Lima, I.F.S.F. Boin. Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation—A Brazilian Multicenter Study. Transplantation Proceedings 2017; 49(4): 863 doi: 10.1016/j.transproceed.2017.01.055
|
| 37 |
Wei Yang, Jin Zhao, Yake Wang, Haiwei Xu, Zhenwei Wu, Yangyang Hu, Kunkun Jiang, Pengpeng Shen, Cuiyun Ma, Zhenzhen Guan, Yan Zhang, Jiahui Ma, Ning Shang, Guangming Yan, Zhenji Wang, Guifu Dai. In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis. Toxicology and Applied Pharmacology 2017; 327: 1 doi: 10.1016/j.taap.2017.04.022
|
| 38 |
Hu Liang, Ji Ai-Jun, Zhang Ji-Zong, Han Jian-Bo, Zhao Liang, Yi Yong-Xiang, Yu Chen. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma. Anti-Cancer Drugs 2019; 30(2): 186 doi: 10.1097/CAD.0000000000000711
|
| 39 |
Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa, Amal M. El Gayar. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sciences 2019; 233: 116673 doi: 10.1016/j.lfs.2019.116673
|
| 40 |
So Young Kim, Hyun Hwangbo, Hyesook Lee, Cheol Park, Gi-Young Kim, Sung-Kwon Moon, Seok Joong Yun, Wun-Jae Kim, Jaehun Cheong, Yung Hyun Choi. Induction of Apoptosis by Coptisine in Hep3B Hepatocellular Carcinoma Cells through Activation of the ROS-Mediated JNK Signaling Pathway. International Journal of Molecular Sciences 2020; 21(15): 5502 doi: 10.3390/ijms21155502
|
| 41 |
Junwei Tang, Yu Xie, Xiaoliang Xu, Yin Yin, Runqiu Jiang, Lei Deng, Zhongming Tan, Venkatanarayana Gangarapu, Jinhai Tang, Beicheng Sun. Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma. Cell Death & Disease 2017; 8(3): e2675 doi: 10.1038/cddis.2017.81
|
| 42 |
Yingshi Zhang, Dandan Li, Fan Feng, Li An, Fuhai Hui, Dasheng Dang, Qingchun Zhao. Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14897-6
|
| 43 |
Deng Huang, Li Cao, Shuguo Zheng. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2017; 36(1) doi: 10.1186/s13046-016-0474-0
|
| 44 |
Xin-Rong Zhang, Jun Ouyang, Jing-Yuan Huang. Quantitative evaluation of blood perfusion in hepatocellular carcinoma after transcatheter arterial chemoembolization by contrast-enhanced ultrasound. World Chinese Journal of Digestology 2019; 27(4): 276 doi: 10.11569/wcjd.v27.i4.276
|
| 45 |
Sujan Chatterjee, Debajyoti Patra, Udipta Chakraborti, Dipanwita Sengupta, Pujita Ghosh, Anupam Basu, Gobinda Chandra Sadhukhan, Kaustav Dutta Chowdhury. Association of p38MAPK‐p53‐Fas aggregation in S‐allyl cysteine mediated regulation of hepatocarcinoma. Environmental Toxicology 2019; 34(8): 928 doi: 10.1002/tox.22764
|
| 46 |
Nida Nayyar Farshori. Hepatoprotective effect of Trigonella foenum graecum against ethanol-induced cell death in human liver cells (HepG2 and Huh7). Molecular Biology Reports 2022; 49(4): 2765 doi: 10.1007/s11033-021-07088-0
|
| 47 |
Kévin Hardonnière, Laurence Huc, Odile Sergent, Jørn A. Holme, Dominique Lagadic-Gossmann. Environmental carcinogenesis and pH homeostasis: Not only a matter of dysregulated metabolism. Seminars in Cancer Biology 2017; 43: 49 doi: 10.1016/j.semcancer.2017.01.001
|
| 48 |
Jin Chen, Xue Li, Qi Cheng, Deng Ning, Jie Ma, Zhi‐Ping Zhang, Xiao‐Ping Chen, Li Jiang. Retracted: Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells. Journal of Cellular Biochemistry 2018; 119(2): 2368 doi: 10.1002/jcb.26400
|
| 49 |
Qiong Wu, Shijun Yu, Jingde Chen, Yandong Li, Yong Gao. Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level. IUBMB Life 2018; 70(2): 120 doi: 10.1002/iub.1707
|
| 50 |
Sebastian Buschauer, Andreas Koch, Philipp Wiggermann, Martina M�ller, Claus Hellerbrand. Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.7887
|
| 51 |
Jianfei Tu, Zhongwei Zhao, Min Xu, Xiaojie Lu, Liu Chang, Jiansong Ji. NEAT1 upregulates TGF‐β1 to induce hepatocellular carcinoma progression by sponging hsa‐mir‐139‐5p. Journal of Cellular Physiology 2018; 233(11): 8578 doi: 10.1002/jcp.26524
|
| 52 |
F. Hartmann, A. Tannapfel. Leberadenome und andere maligne und benigne Lebertumoren. Der Gastroenterologe 2016; 11(5): 359 doi: 10.1007/s11377-016-0097-1
|
| 53 |
Angelica Singh, Sofia Zahid, Ilya Noginskiy, Timothy Pak, Soeb Usta, Marina Barsoum, Uqba Khan. A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma. Current Oncology 2022; 29(9): 6445 doi: 10.3390/curroncol29090507
|
| 54 |
Hande Karamahmutoglu, Meltem Elitas, Tamer Yagci, Metin Çetin, Bonnie L. Gray, Holger Becker. Behavior of HepG2 liver cancer cells using microfluidic-microscopy: a preliminary study. Microfluidics, BioMEMS, and Medical Microsystems XVI 2018; : 33 doi: 10.1117/12.2289863
|
| 55 |
Amir Tiyuri, Shayeste Sadat Baghermanesh, Yasamin Davatgaran-Taghipour, Seyed Sadegh Eslami, Nasibeh Shaygan, Houman Parsaie, Mahmood Barati, Davod Jafari. Diagnostic accuracy of serum derived exosomes for hepatocellular carcinoma: a systematic review and meta-analysis. Expert Review of Molecular Diagnostics 2023; 23(11): 971 doi: 10.1080/14737159.2023.2260306
|
| 56 |
Aldona Kasprzak, Wojciech Kwasniewski, Agnieszka Adamek, Anna Gozdzicka-Jozefiak. Insulin-like growth factor (IGF) axis in cancerogenesis. Mutation Research/Reviews in Mutation Research 2017; 772: 78 doi: 10.1016/j.mrrev.2016.08.007
|
| 57 |
Georgios Kareliotis, Maria Papachristou, Dimitrios Priftakis, Ioannis Datseris, Mersini Makropoulou. Computational study of necrotic areas in rat liver tissue treated with photodynamic therapy. Journal of Photochemistry and Photobiology B: Biology 2019; 192: 40 doi: 10.1016/j.jphotobiol.2019.01.007
|
| 58 |
Fereshteh Aslani, Reza Afarin, Nafiseh Dehghani Madiseh, Hasti Beheshti Nasab, Sajad Monjezi, Somayeh Igder, Mojtaba Rashidi. Potentiation of Apoptotic Effect of Combination of Etoposide and Quercetin on HepG2 Liver Cancer Cells. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-136194
|
| 59 |
Changyong E, Chunsheng Li, Hang Li, Jinghui Yang. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR‐5095 from MBD2. Journal of Cellular Physiology 2019; 234(10): 18504 doi: 10.1002/jcp.28486
|
| 60 |
Ramesh P Thylur, Sanjit K Roy, Anju Shrivastava, Thomas A LaVeist, Sharmila Shankar, Rakesh K Srivastava. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma . JGH Open 2020; 4(3): 351 doi: 10.1002/jgh3.12336
|
| 61 |
P. Muriel, E. Fernández-Martínez, S. Montes. Liver Pathophysiology. 2017; : 427 doi: 10.1016/B978-0-12-804274-8.00033-3
|
| 62 |
Shahid Rasool, Muhammad Ibrahim, Mulazim Hussain, Muhammad Ajmal Shah, Adnan Amin. Phytonutrients in the Treatment of Gastrointestinal Cancer. 2023; : 209 doi: 10.2174/9789815049633123010012
|
| 63 |
Jing-Ling Zhu, Sidney Wing-Kwong Yu, Pierce Kah-Hoe Chow, Yen Wah Tong, Jun Li. Controlling injectability and in vivo stability of thermogelling copolymers for delivery of yttrium-90 through intra-tumoral injection for potential brachytherapy. Biomaterials 2018; 180: 163 doi: 10.1016/j.biomaterials.2018.07.023
|
| 64 |
Umar Farooq, Hao Wang, Jingru Hu, Guangyue Li, Shah Jehan, Jinming Shi, Dangdang Li, Guangchao Sui. Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery. Cells 2023; 12(2): 222 doi: 10.3390/cells12020222
|
| 65 |
Soo Kim. Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal Cancer. International Journal of Molecular Sciences 2016; 17(7): 1155 doi: 10.3390/ijms17071155
|
| 66 |
Peng Sheng Yi, Yong Li, Shu Yan, Bin Wu, Chuan Lan, Jian Shui Li. Surgery combined with post-operative trancatheter arterial chemoembolization improves survival of intermediate hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2019; 54(2): 240 doi: 10.1080/00365521.2019.1577487
|
| 67 |
María Paulette Castro-Gil, Julia Esperanza Torres-Mena, Rosa M. Salgado, Said A. Muñoz-Montero, José Michael Martínez-Garcés, Carlos David López-Torres, Alfredo Mendoza-Vargas, Nayeli Belem Gabiño-López, Saúl Villa-Treviño, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Edgar Krötzsch, Julio Isael Pérez-Carreón. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism. Genomics 2022; 114(1): 72 doi: 10.1016/j.ygeno.2021.11.035
|
| 68 |
Anna Buttell, Wei Qiu. The action and resistance mechanisms of Lenvatinib in liver cancer. Molecular Carcinogenesis 2023; 62(12): 1918 doi: 10.1002/mc.23625
|
| 69 |
Meng-Na He, Ke Lv, Yu-Xin Jiang, Tian-An Jiang. Application of superb microvascular imaging in focal liver lesions. World Journal of Gastroenterology 2017; 23(43): 7765-7775 doi: 10.3748/wjg.v23.i43.7765
|
| 70 |
Y. Sheena Mary, Y. Shyma Mary, Ali Shokuhi Rad, Rohitash Yadav, Ismail Celik, S. Sarala. Theoretical investigation on the reactive and interaction properties of sorafenib – DFT, AIM, spectroscopic and Hirshfeld analysis, docking and dynamics simulation. Journal of Molecular Liquids 2021; 330: 115652 doi: 10.1016/j.molliq.2021.115652
|
| 71 |
Elena De Mattia, Erika Cecchin, Jerry Polesel, Francesco Lupo, Claudio Tiribelli, Marina Crovatto, Angela Buonadonna, Giuseppe Toffoli. UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver International 2017; 37(9): 1345 doi: 10.1111/liv.13411
|
| 72 |
Ja Il Koo, Hyo-Jung Lee, Ji Hoon Jung, Eunji Im, Ju-Ha Kim, Nari Shin, Deok Yong Sim, Jisung Hwang, Sung-Hoon Kim. The Pivotal Role of Long Noncoding RNA RAB5IF in the Proliferation of Hepatocellular Carcinoma via LGR5 Mediated β-Catenin and c-Myc Signaling. Biomolecules 2019; 9(11): 718 doi: 10.3390/biom9110718
|
| 73 |
Michael Odutola, Elima E. Jedy-Agba, Eileen O. Dareng, Emmanuel Aja Oga, Festus Igbinoba, Theresa Otu, Emmanuel Ezeome, Ramatu Hassan, Clement A. Adebamowo. Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012–2014. Frontiers in Oncology 2016; 6 doi: 10.3389/fonc.2016.00216
|
| 74 |
Dan Jiang, William C. Cho, Zhenhao Li, Xiangrong Xu, Yuliang Qu, Zhongjia Jiang, Le Guo, Guangxian Xu. MiR-758-3p suppresses proliferation, migration and invasion of hepatocellular carcinoma cells via targeting MDM2 and mTOR. Biomedicine & Pharmacotherapy 2017; 96: 535 doi: 10.1016/j.biopha.2017.10.004
|
| 75 |
Ariane Aigelsreiter, Jens Neumann, Martin Pichler, Judith Halasz, Kurt Zatloukal, Andrea Berghold, Philipp Douschan, Florian Rainer, Rudolf Stauber, Johannes Haybaeck, Helmut Denk, Carolin Lackner. Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis. Liver International 2017; 37(4): 600 doi: 10.1111/liv.13325
|
| 76 |
William T. N. Culp, Eric G. Johnson, Michelle A. Giuffrida, Robert B. Rebhun, James K. Cawthra, Heidi A. Schwanz, Jenna H. Burton, Michael S. Kent, Douglas H. Thamm. Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs. PLOS ONE 2022; 17(8): e0269941 doi: 10.1371/journal.pone.0269941
|
| 77 |
EL-Hassan M. Mokhamer, Abdel-Aziz A. Zidan, Nourhan K. El.Ghayesh, Karolin K. Abdel-Aziz. Attenuation of trichloroacetic acid-induced hepatocellular carcinoma by Artemisia judaica ethanolic extract in male rats. The Journal of Basic and Applied Zoology 2022; 83(1) doi: 10.1186/s41936-022-00264-z
|
| 78 |
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
|
| 79 |
Shaikh Afaq, Jayesh M. Soni, Anil K. Pillai. Liver Diseases. 2020; : 687 doi: 10.1007/978-3-030-24432-3_63
|
| 80 |
Ping Sui, Xiaoyan Wang, Lipeng Sun, Hui Wang. Diagnostic accuracy of ultrasound superb microvascular imaging for focal liver lesions. Medicine 2021; 100(3): e24411 doi: 10.1097/MD.0000000000024411
|
| 81 |
Chongsheng Xia, Yurui Sun, Yang Li, Junli Ma, Jing Shi. LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11644-4
|
| 82 |
Rimpy Diwan, Samantha Lynn Gaytan, Himanshu Narendrakumar Bhatt, Jacqueline Pena-Zacarias, Md Nurunnabi. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities. Drug Delivery and Translational Research 2024; 14(10): 2743 doi: 10.1007/s13346-024-01551-8
|
| 83 |
Wei Li, Yu-Hong Tian, Ying Liu, Zi Wang, Shan Tang, Jing Zhang, Ying-Ping Wang. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis. The Journal of Toxicological Sciences 2016; 41(3): 417 doi: 10.2131/jts.41.417
|
| 84 |
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
|
| 85 |
Walifa Waqar, Sidra Asghar, Sobia Manzoor, Gianfranco D. Alpini. Platelets’ RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules. PLOS ONE 2021; 16(9): e0256739 doi: 10.1371/journal.pone.0256739
|
| 86 |
Qiaoyou Weng, Minjiang Chen, Maoquan Li, Yong-Fa Zheng, Guoliang Shao, Weijun Fan, Xi-Ming Xu, Jiansong Ji. Global microarray profiling identifiedhsa_circ_0064428as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. Journal of Medical Genetics 2019; 56(1): 32 doi: 10.1136/jmedgenet-2018-105440
|
| 87 |
Marwa S. Abd Allah, Gehan M. Elosaily. Immuohistochemical expression and significance of NADPH oxidase 1 and CXCR4 in hepatitis C virus-induced hepatocellular carcinoma. Egyptian Journal of Pathology 2018; 38(1): 120 doi: 10.1097/01.XEJ.0000542234.06636.ab
|
| 88 |
Julius Dongsogo, Christopher Larbie. Association of metabolic syndrome with the risk of developing liver disease in chronic hepatitis B patients. African Journal of Biochemistry Research 2019; 13(2): 23 doi: 10.5897/AJBR2017.0956
|
| 89 |
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism. Cytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
|
| 90 |
Junli Ma, Shan Zeng, Yan Zhang, Ganlu Deng, Yanling Qu, Cao Guo, Ling Yin, Ying Han, Hong Shen. BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling. Molecular Carcinogenesis 2017; 56(10): 2279 doi: 10.1002/mc.22681
|
| 91 |
Han-Hee Park, Seung-Won Choi, Gwang Jin Lee, Young-Dae Kim, Hyun-Jin Noh, Seung-Jae Oh, Iseul Yoo, Yu-Jin Ha, Gi-Bang Koo, Soon-Sun Hong, Sung Won Kwon, You-Sun Kim. A formulated red ginseng extract inhibits autophagic flux and sensitizes to doxorubicin-induced cell death. Journal of Ginseng Research 2019; 43(1): 86 doi: 10.1016/j.jgr.2017.08.006
|
| 92 |
Iuliia Taskaeva, Nataliya Bgatova, Izabella Gogaeva. Lithium effects on vesicular trafficking in hepatocellular carcinoma cells. Ultrastructural Pathology 2019; 43(6): 301 doi: 10.1080/01913123.2019.1701167
|
| 93 |
Da Xu, Jessica Qiuhua Sheng, Paul Jen-Hwa Hu, Ting Shuo Huang, Wei-Chen Lee. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables. Journal of Biomedical Informatics 2019; 96: 103237 doi: 10.1016/j.jbi.2019.103237
|
| 94 |
Heikki Huhta, Olli Helminen, Joonas H. Kauppila, Tuula Salo, Katja Porvari, Juha Saarnio, Petri P. Lehenkari, Tuomo J. Karttunen. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. Journal of Histochemistry & Cytochemistry 2016; 64(8): 470 doi: 10.1369/0022155416656154
|
| 95 |
E. U. Mbuk, E. I Amber. Retrospective study on gastrointestinal tract tumors in humans in Zaria, Kaduna State, Nigeria. Journal of Cancer Research and Experimental Oncology 2017; 9(1): 1 doi: 10.5897/JCREO2017.0146
|
| 96 |
Landon L. Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W. Houchen. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences 2024; 25(12): 6481 doi: 10.3390/ijms25126481
|
| 97 |
Tsinat Berhane, Anja Holm, Kasper Thystrup Karstensen, Andreas Petri, Mirolyuba Simeonova Ilieva, Henrik Krarup, Mogens Vyberg, Marianne Bengtson Løvendorf, Sakari Kauppinen. Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicin. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23802-9
|